Lawsuits Against Gilead’s HIV Drug, Truvada
Tenofovir, a tenofovir disoproxil fumarate (TDF) drug, treats HIV infections, and since 2012, has been used as pre-exposure prophylaxis (PrEP) for HIV. However, TDF drugs like Tenofovir have been linked to severe side-effects such as chronic kidney disease, bone density loss and fracturing. Lawsuits have been filed against the drug manufacturer, Gilead Sciences, Inc., concerning these conditions, along with claims that that the company knew of the harmful side effects, but withheld a safer alternative, tenofovir alafenamide (TAF), to reap profits from the patent it controlled over Tenofovir. In fact, Gilead had a monopoly on the life-saving drug until October 2020, costing American users roughly $1,700 per month.
The delayed release of Gilead’s TAF drugs has allegedly caused tens of thousands of HIV patients to develop injuries unnecessarily. These victims have suffered injuries and amassed enormous medical bills fighting to regain their health.
Do You Believe You Have a TDF HIV Drug Claim?
If you took Tenofovir®, Viread®, Atripla®, Complera®, or Stribild® to treat or prevent HIV and experienced kidney or bone injuries, you may be eligible to file a lawsuit and seek compensation.
Kidney problems may include:
- Acute Kidney Injury or Acute Renal Failure
- Chronic Kidney Disease or declining kidney function
- Fanconi’s syndrome
- Kidney tubular dysfunction
Bone injuries may include:
- Bone fractures
It’s not too late to investigate your claim. Contact our law firm for a free confidential case evaluation. We offer a free initial case evaluation. You can submit an online form or call us at (888) 984-7988 for a confidential evaluation of your potential claim.